Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M453Revenue $M7.9Net Margin (%)16.8Z-Score5.1
Enterprise Value $M365EPS $-0.8Operating Margin %15.5F-Score6
P/E(ttm))130Cash Flow Per Share $0.4Pre-tax Margin (%)15.5Higher ROA y-yY
Price/Book3.310-y EBITDA Growth Rate %0Quick Ratio21.3Cash flow > EarningsN
Price/Sales9.05-y EBITDA Growth Rate %0Current Ratio21.3Lower Leverage y-yY
Price/Cash Flow6.4y-y EBITDA Growth Rate %0ROA % (ttm)5.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)7.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M69.6ROI % (ttm)-48.7Gross Margin Increase y-yY

Gurus Latest Trades with PGNX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PGNXJulian Robertson 2014-09-30 Buy 1.8%$4.15 - $5.56
($4.99)
$ 6.5130%New holding, 1290055 sh.1,290,055
PGNXJohn Hussman 2009-06-30 Sold Out -0.02%$4.53 - $6.84
($5.48)
$ 6.5119%Sold Out0
PGNXJohn Hussman 2008-09-30 Buy 0.04%$12.19 - $17.07
($14.9)
$ 6.51-56%New holding, 100000 sh.100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PGNX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PGNX Julian Robertson 2014-12-311,288,4541.851.9-0.12%
Premium Most recent portfolio changes are included for Premium Members only!


PGNX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ISRAEL ROBERT JExecutive Vice President, Medi 2015-01-12Sell2,000$7.06-7.79view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-12-11Sell3,000$7.07-7.92view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-21Sell9,000$7-7view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-13Sell10,000$6.83-4.69view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-11Sell5,000$6.53-0.31view
Broadfin Healthcare Master Fun10% Owner 2014-07-21Buy1,625,436$4.641.52view
ISRAEL ROBERT JSenior VP Medical Affairs 2013-07-18Sell5,000$6.332.84view
Baker Mark RobertCEO 2013-03-27Buy650$5.3222.37view
Baker Mark RobertCEO 2013-02-27Buy1,262$2.72139.34view
Baker Mark RobertCEO 2013-01-22Buy1,215$2.82130.85view

Press Releases about PGNX :

    Quarterly/Annual Reports about PGNX:

    News about PGNX:

    Articles On GuruFocus.com
    Tiger Management’s Julian Robertson Buys Alibaba, eBay, MasTec, Sells Tableau Software, Monsanto, Nov 14 2014 
    Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street Nov 07 2014 
    Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX Jan 26 2013 
    Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX Jan 27 2013 
    Weekly CEO Buys Highlight: SUSP, ROVI, ZLC, MDW, PGNX Oct 01 2012 
    5 Stocks That Dropped the Most Since Gurus Bought Them Sep 13 2012 
    Dendreon Could Push Higher If New Drug Trials Succeed Apr 23 2012 
    Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Dec 01 2010 
    Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 08 2010 
    Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Nov 02 2010 

    More From Other Websites
    Nasdaq stocks posting largest percentage increases Feb 27 2015
    Progenics Pharmaceuticals Presents Positive Phase 2 Data for PSMA ADC in Metastatic... Feb 26 2015
    Progenics Pharmaceuticals Presents Positive Phase 2 Data for PSMA ADC in Metastatic... Feb 26 2015
    11:30 am Progenics Pharm announces positive Phase 2 data for PSMA ADC in metastatic... Feb 26 2015
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 24 2015
    Progenics Pharmaceuticals to Present Full Phase 2 Data for PSMA ADC at the 2015 ASCO GU Symposium Feb 23 2015
    Progenics Pharmaceuticals to Present Full Phase 2 Data for PSMA ADC at the 2015 ASCO GU Symposium Feb 23 2015
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 18 2015
    Progenics Pharmaceuticals to Present at the 2015 RBC Capital Markets' Healthcare Conference Feb 17 2015
    Progenics Pharmaceuticals to Present at the 2015 RBC Capital Markets' Healthcare Conference Feb 17 2015
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 04 2015
    Progenics Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference Feb 03 2015
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 23 2015
    Progenics Pharmaceuticals Relaunches Pivotal Trial of AZEDRA(TM) in Pheochromocytoma Jan 23 2015
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 02 2014
    Progenics Pharmaceuticals Announces Presentation at RSNA Annual Meeting Dec 02 2014
    Progenics Pharmaceuticals Announces Presentation at RSNA Annual Meeting Dec 02 2014
    Progenics (PGNX) Shares March Higher, Can It Continue? Nov 17 2014
    PROGENICS PHARMACEUTICALS INC Financials Nov 15 2014
    Tiger Management's Julian Robertson Buys Alibaba, eBay, MasTec, Sells Tableau Software, ... Nov 14 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK